Legend: : Special Mention  : Important : Very Important : Key Development |
| |
| |
Susceptibility to antivirals of a human HBV strain with mutations conferring resistance to both lamivudine and adefovir.
MN Brunelle, AC Jacquard, C Pichoud, D Durantel, S Carrouée-Durantel, JP Villeneuve, C Trépo, F Zoulim, Hepatology. 2005 Jun:1391-8 |
| |
Therapeutic effect of autologous dendritic cell vaccine on patients with chronic hepatitis B: a clinical study.
M Chen, YG Li, DZ Zhang, ZY Wang, WQ Zeng, XF Shi, Y Guo, SH Guo, H Ren, World J Gastroenterol. 2005 Mar 28:1806-8 |
| |
Cationic polymers that enhance the performance of HbsAg DNA in vivo.
GW Bos, T Kanellos, DJ Crommelin, WE Hennink, CR Howard, Vaccine. 2004 Dec 9:460-9 |
| |
Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation.
I Desombere, T Cao, Y Gijbels, G Leroux-Roels, Clin Exp Immunol. 2005 Apr:126-37 |
| |
Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study.
MA Hernán, SS Jick, MJ Olek, H Jick, Neurology. 2004 Sep 14:838-42 |
| |
A survey on the prevalence and management of hepatitis B after renal transplantation in Asian-Pacific countries.
TM Chan, J Chapman, CJ Lee, Z Morad, ET Ona, K Park, A Pingle, SA Rizvi, FA Shaheen, V Sumethkul, XD Tang, Y Watarai, Transplant Proc. 2004 Sep:2126-7 |
| |
Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
B Duval, V Gîlca, N Boulianne, P De Wals, R Massé, G Trudeau, G De Serres, Pediatr Infect Dis J. 2005 Mar:213-8 |
| |
Hepatitis B surface antigen presentation and HLA-DRB1*- lessons from twins and peptide binding studies.
A Kruger, P Adams, J Hammer, WO B&oeig;cher, PM Schneider, C Rittner, T Hoehler, Clin Exp Immunol. 2005 May:325-32 |
| |
Hepatitis B virus: significance of genotypes.
S Schaefer, J Viral Hepat. 2005 Mar:111-24 |
| |
Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
F Fabrizi, V Dixit, M Magnini, A Elli, P Martin, Aliment Pharmacol Ther. 2006 Aug 1:497-506 |
| |
Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease.
F Fabrizi, SV Ganeshan, V Dixit, P Martin, Aliment Pharmacol Ther. 2006 Sep 1:789-96 |
| |
Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
F Fabrizi, V Dixit, P Martin, Aliment Pharmacol Ther. 2006 Jun 1:1559-66 |
| |
Sexual transmission of hepatitis B.
M Atkins, M Nolan, Curr Opin Infect Dis. 2005 Feb:67-72 |
| Supplementary evidence: |
| |
A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: analysis of the Vaccine Adverse Event Reporting System (VAERS) data
MR Geier, DA Geier, Clin Exp Rheumatol. 2004 Nov-Dec:749-55 |
| |
A promising therapeutic vaccination to suppress hepatitis B virus replication in immunosuppressed patients.
M Imawari, J Gastroenterol. 2004 Sep:913-4 |
| |
A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
P Van Damme, K Van Herck, Expert Rev Vaccines. 2004 Jun:249-67 |
| |
Acceptability of universal hepatitis B vaccination among school pupils and parents.
A Hinds, JC Cameron, Commun Dis Public Health. 2004 Dec:278-82 |
| |
Acceptance and completion of hepatitis B vaccination among drug users in New York City.
DC Ompad, S Galea, Y Wu, CM Fuller, M Latka, B Koblin, D Vlahov, Commun Dis Public Health. 2004 Dec:294-300 |
| |
Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
BJ McMahon, DL Bruden, KM Petersen, LR Bulkow, AJ Parkinson, O Nainan, M Khristova, C Zanis, H Peters, HS Margolis, Ann Intern Med. 2005 Mar 1:333-41 |
| |
Clinical practice: prevention of hepatitis B with the hepatitis B vaccine.
GA Poland, RM Jacobson, N Engl J Med. 2004 Dec 30:2832-8 |
| |
Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response.
CA Siegrist, M Pihlgren, C Tougne, SM Efler, ML Morris, MJ AlAdhami, DW Cameron, CL Cooper, J Heathcote, HL Davis, PH Lambert, Vaccine. 2004 Dec 16:615-22 |
| |
Cost-effectiveness of hepatitis A-B vaccine versus hepatitis B vaccine for healthcare and public safety workers in the western United States.
RJ Jacobs, GA Gibson, AS Meyerhoff, Infect Control Hosp Epidemiol. 2004 Jul:563-9 |
| |
Determining the point of indifference--where costs of selective and universal immunization against hepatitis B are identical, in a cost-minimization exercise.
RM Varghese, J Abraham, J James, JM Puliyel, Indian J Gastroenterol. 2004 Jul-Aug:154-6 |
| |
Development of a nasal vaccine for chronic hepatitis B infection that uses the ability of hepatitis B core antigen to stimulate a strong Th1 response against hepatitis B surface antigen.
JC Aguilar, Y Lobaina, V Muzio, D García, E Pentón, E Iglesias, D Pichardo, D Urquiza, D Rodríguez, D Silva, N Petrovsky, G Guillén, Immunol Cell Biol. 2004 Oct:539-46 |
| |
Development of a single-dose stabilized poly(D,L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B.
KS Jaganathan, P Singh, D Prabakaran, V Mishra, SP Vyas, J Pharm Pharmacol. 2004 Oct:1243-50 |
| |
Does efficient haemodialysis improve the response to hepatitis B virus vaccination?
V Kovaci., M Sain, V Vukman, Lijec Vjesn. 2004 May-Jun:133-7 |
| |
Dramatic decline in acute hepatitis B infection and disease incidence rates among adolescents and young people after 12 years of a mass hepatitis B vaccination programme of pre-adolescents in the scho
L Salleras, A Dominguez, M Bruguera, N Cardeñosa, J Batalla, G Carmona, E Navas, JL Taberner, Vaccine. 2005 Mar 18:2181-4 |
| |
Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine. Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation schedule.
F Fagnani, C Le Fur, I Durand, M Gibergy, Eur J Health Econ. 2004 Jun:143-9 |
| |
Effectiveness of hepatitis B vaccination in children of chronic hepatitis B mothers.
P Adibi, R Ghassemian, SM Alavian, M Ranjbar, AH Mohammadalizadeh, F Nematizadeh, M Mamani, M Rezazadeh, F Keramat, A Ardalan, A Esmaeili, MR Zali, Saudi Med J. 2004 Oct:1414-8 |
| |
Efficacy of hepatitis B vaccination and interferon-alpha-2b combination therapy versus interferon-alpha-2b monotherapy in children with chronic hepatitis B.
M Helvaci, A Kizilgunesler, E Kasirga, E Ozbal, M Kuzu, G Sozen, J Gastroenterol Hepatol. 2004 Jul:785-91 |
| |
Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
E Navas, L Salleras, R Gisbert, A Dominguez, M Bruguera, G Rodríguez, N Galí, A Prat, Vaccine. 2005 Mar 18:2185-9 |
| |
Evolution of strategy and coverage rates for hepatitis B vaccination in France, a country with low endemicity
F Denis, V Abitbol, A Aufrère, Med Mal Infect. 2004 Apr:149-58 |
| |
Factors associated with fulminant liver failure during an outbreak among injection drug users with acute hepatitis B.
RS Garfein, WA Bower, CM Loney, YJ Hutin, GL Xia, J Jawanda, AV Groom, OV Nainan, JS Murphy, BP Bell, Hepatology. 2004 Oct:865-73 |
| |
Factors associated with receiving hepatitis B vaccination among high-risk adults in the United States: an analysis of the National Health Interview Survey, 2000.
N Jain, H Yusuf, PM Wortley, GL Euler, S Walton, S Stokley, Fam Med. 2004 Jul-Aug:480-6 |
| |
Genetic regulation of immune responses to vaccines in early life.
MJ Newport, T Goetghebuer, HA Weiss, H Whittle, CA Siegrist, A Marchant, MRC Gambia Twin Study Group, Genes Immun. 2004 Mar:122-9 |
| |
HBV vaccination should be performed in service centres for drug users: an Italian experience.
G Quaglio, F Lugoboni, P Mezzelani, J Public Health (Oxf). 2004 Sep:320 |
| |
Hepatitis B and C. Risk of transmission from infected health care workers to patients
WH Gerlich, Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Apr:369-78 |
| |
Hepatitis B and hepatitis C viruses in liver transplantation.
MP Curry, Transplantation. 2004 Oct 15:955-63 |
| |
Hepatitis B mother--to--child transmission.
S Ranger-Rogez, F Denis, Expert Rev Anti Infect Ther. 2004 Feb:133-45 |
| |
Hepatitis B vaccination associated with higher female than male mortality in Guinea-bissau: an observational study.
ML Garly, H Jensen, CL Martins, C Balé, MA Baldé, IM Lisse, P Aaby, Pediatr Infect Dis J. 2004 Dec:1086-92 |
| |
Hepatitis B vaccination coverage in Belgian health care workers.
R Vranckx, P Jacques, A De Schrijver, G Moens, Infection. 2004 Oct:278-81 |
| |
Hepatitis B vaccination for patients with chronic renal failure.
RJ Schroth, CA Hitchon, J Uhanova, A Noreddin, SP Taback, ME Moffatt, JM Zacharias, Cochrane Database Syst Rev. 2004:CD003775 |
| |
Hepatitis B vaccination in France: vaccination coverage in 2002
F Denis, Bull Acad Natl Med. 2004:115-23 |
| |
Hepatitis B vaccines.
AS Yu, RC Cheung, EB Keeffe, Clin Liver Dis. 2004 May:283-300 |
| |
Hepatitis B vaccines.
[No Authors Listed], Wkly Epidemiol Rec. 2004 Jul 9:255-63 |
| |
Hepatitis B: epidemiology and natural history.
TT Tran, P Martin, Clin Liver Dis. 2004 May:255-66 |
| |
High seroprotection rate induced by intradermal administration of a recombinant hepatitis B vaccine in young healthy adults: comparison with standard intramuscular vaccination.
MJ Ghabouli, AH Sabouri, N Shoeibi, SN Bajestan, H Baradaran, Eur J Epidemiol. 2004:871-5 |
| |
Identification of the immunogenic domains in HBsAg preS1 region using overlapping preS1 fragment fusion proteins.
WG Hu, J Wei, HC Xia, XX Yang, F Li, GD Li, Y Wang, ZC Zhang, World J Gastroenterol. 2005 Apr 14:2088-94 |
| |
Immunogenicity and safety of hepatitis B vaccine (Shanvac-B) using a novel pre-filled single use injection device Uniject in Indian subjects.
N Joshi, A Kumar, MB Raghu, S Bhave, R Arulprakash, P Bhusari, R Rao, Indian J Med Sci. 2004 Nov:472-7 |
| |
Incidence of viral hepatitis B and vaccination in the Arkhangelsk region, Russian Federation.
A Tulisov, R Buzinov, T Gordienko, Int J Circumpolar Health. 2004:205-8 |
| |
Lichen planus induced by hepatitis B vaccination: a new case and review of the literature.
D Calista, M Morri, Int J Dermatol. 2004 Aug:562-4 |
| |
Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.
EH Boxall, J A Sira, N El-Shuhkri, DA Kelly, J Infect Dis. 2004 Oct 1:1264-9 |
| |
Long-term protection of hepatitis B vaccine: lessons from Alaskan experience after 15 years.
DS Chen, Ann Intern Med. 2005 Mar 1:384-5 |
| |
Management of hepatitis B in children.
A Broderick, MM Jonas, Clin Liver Dis. 2004 May:387-401 |
| |
Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.
A Godkin, M Davenport, AV Hill, Hepatology. 2005 Jun:1383-90 |
| |
Much gained by integrating contact tracing and vaccination in the hepatitis B antenatal screening program in Amsterdam, 1992-1999.
JE van Steenbergen, D Baayen, PG Peerbooms, RA Coutinho, A Van Den Hoek, J Hepatol. 2004 Jun:979-85 |
| |
Practical difficulties in the management of hepatitis B in the Asia-Pacific region.
R Mohamed, P Desmond, DJ Suh, D Amarapurkar, E Gane, Y Guangbi, JL Hou, W Jafri, CL Lai, CH Lee, SD Lee, SG Lim, R Guan, PH Phiet, T Piratvisuth, J Sollano, JC Wu, J Gastroenterol Hepatol. 2004 Sep:958-69 |
| |
Preventing and treating hepatitis B infection.
R Aggarwal, P Ranjan, BMJ. 2004 Nov 6:1080-6 |
| |
Preventing and treating hepatitis B infection: immunisation is most important strategy to control hepatitis B.
OD Mansoor, N Wilson, BMJ. 2005 Jan 22:197-8 |
| |
Prevention of hepatitis B in juveniles. Effect of a medical health education lesson in school
C Layer, G Gille, C Klapp, U Ravens-Sieberer, Med Klin (Munich). 2004 Dec 15:703-7 |
| |
Prisoners' attitudes toward Hepatitis B vaccination.
S Vallabhaneni, GE Macalino, SE Reinert, B Schwartzapfel, FA Wolf, JD Rich, Prev Med. 2004 Jun:828-33 |
| |
Protection of children born to hepatitis-B-infected mothers
HJ Boot, PE Vermeer-de Bondt, TG Kimman, Ned Tijdschr Geneeskd. 2004 Sep 11:1816-8 |
| |
Recombivax-HB: perspectives past, present and future.
C Venters, W Graham, W Cassidy, Expert Rev Vaccines. 2004 Apr:119-29 |
| |
Review article: hepatitis vaccination in patients with chronic liver disease.
G Reiss, EB Keeffe, Aliment Pharmacol Ther. 2004 Apr 1:715-27 |
| |
Routine infant hepatitis B vaccination recommendations.
SG Humiston, GS Marshall, Pediatr Ann. 2004 Aug:515-22 |
| |
Seroprevalence of hepatitis B and C in the Western Brazilian Amazon region (Rio Branco, Acre): a pilot study carried out during a hepatitis B vaccination program.
J Tavares-Neto, D Almeida, MC Soares, R Uchoa, S Viana, R Darub, E Farias, G Rocha, L Vitvitski, R Paraná, Braz J Infect Dis. 2004 Apr:133-9 |
| |
Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.
HY Hsu, MH Chang, YH Ni, HL Chen, Gut. 2004 Oct:1499-503 |
| |
Systemic adverse effects of hepatitis B vaccines are rare.
[No Authors Listed], Prescrire Int. 2004 Dec:218-23 |
| |
The evaluation of immune responses that occur after HBV infection and HBV vaccination in hemodialysis patients.
IH Kara, ME Yilmaz, A Suner, AK Kadiroglu, B Isikoglu, Vaccine. 2004 Sep 28:3963-7 |
| |
The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation.
L Goncalves, B Albarran, S Salmen, L Borges, H Fields, H Montes, A Soyano, Y Diaz, L Berrueta, Virology. 2004 Aug 15:20-8 |
| |
The risk of contracting hepatitis A or hepatitis B run by visitors to the Mediterranean and Eastern Europe
S Pr&oeig;ll, HD Nothdurft, MMW Fortschr Med. 2004 May 13:51-4 |
| |
To vaccinate or not to vaccinate--that is the question: why are some mothers opposed to giving their infants hepatitis B vaccine?
A Maayan-Metzger, P Kedem-Friedrich, J Kuint, Vaccine. 2005 Mar 14:1941-8 |
| |
Vaccinated but not immunized: protection against hepatitis B in medical staff in the developing world.
JS Sorabjee, R Garje, J Hosp Infect. 2004 Oct:164-5 |
| |
Vaccination against hepatitis B virus: ANAES and INSERM experts take a view
F Degos, Gastroenterol Clin Biol. 2004 Jan:50-3 |
| |
Vaccine coverage with hepatitis B and other vaccines in the Colombian Amazon: do health worker knowledge and perception influence coverage?
F de la Hoz, L Perez, JG Wheeler, M de Neira, AJ Hall, Trop Med Int Health. 2005 Apr:322-9 |
| |
Vaccines for neonatal viral infections: hepatitis B vaccine.
FT Cutts, AJ Hall, Expert Rev Vaccines. 2004 Aug:349-52 |
| |
Virology, epidemiology and transmission mechanisms of hepatitis B virus
D Moreno, F Alegre, N García-González, An Sist Sanit Navar. 2004:7-16 |